FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents a method of producing a water-soluble lyophilisate, involving producing a combined solution of an active substance and a compound containing hydroxyl and amino groups (amino alcohol), characterized by that the active substance is 4-((3-oxo-3-ethoxypropanoyl)amino)benzoic acid (EPABA) possessing anti-ischemic and antioxidant activity. Amino alcohol is selected from a group of N-methylglucamine or tris(hydroxymethyl)aminomethane; herewith the said substance and amino alcohol taken in the molar ratio from 1:1 to 1:10 are dissolved in water, the solution is added with an acid agent up to pH 6.8-7.5, neutral solution is filtered, frozen and dried by sublimation.
EFFECT: invention enables to obtain water-soluble stable neutral lyophilisates of EPABA corresponding to process requirements of preparations for parenteral administration.
3 cl, 4 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE LIQUID PHARMACEUTICAL COMPOSITION OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DISUCCINATE COMPLEX, HAVING ANTIHYPOXIC, ANTIOXIDANT AND ADAPTOGENIC ACTION | 2013 |
|
RU2527347C1 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| METHOD FOR PREPARING WATER-SOLUBLE LYOPHILIZED SALT FORM BIS(2-THIO-4,6-DIOXO-1,2,3,4,5,6-HEXAHYDROPYRIMIDIN-5-YL)-(4-NITROPHENYL)METHANE | 2017 |
|
RU2666148C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE WITH COMPLEXANT FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545902C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY AND METHOD FOR PREPARING IT | 2013 |
|
RU2545833C1 |
| RACEMIC OR OPTICALLY ACTIVE ESTER DERIVATIVES OF TRANS-APOVIN CAMINIC ACID | 1996 |
|
RU2161157C2 |
| METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION OF ROCURONIUM BROMIDE IN THE FORM OF A STABLE LYOPHILISATE AND PHARMACEUTICAL COMPOSITION OBTAINED USING SAID METHOD | 2013 |
|
RU2594062C2 |
| METHOD OF PRODUCING A LYOPHILIZED PRODUCT FROM HYDROLYSATES OF BIVALVE MOLLUSCS | 2024 |
|
RU2819659C1 |
| PHARMACEUTICAL COMPOSITION FOR PRODUCING A LYOPHILISATE OF LIVER CELL CULTURE ENRICHED WITH HEPATOCYTE GROWTH FACTOR | 2021 |
|
RU2781448C1 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
